🔎 Trials Near Me

Home › Cardiovascular Disease › Wisconsin

Cardiovascular Disease clinical trials in Wisconsin

15 studies for Cardiovascular Disease are looking for participants at sites in Wisconsin.

Cities in Wisconsin

ELEVATE-HFpEF Clinical Study

  • Froedtert Hospital, Milwaukee
Recruiting
Ages 40 and older · All sexes · Updated Oct 2, 2026 · NCT06678841

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Clinical Investigation Specialists, Inc.-Kenosha-69111, Kenosha
  • Allegiance Research Specialists, Wauwatosa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • Bellin Memorial Hospital, Green Bay
  • Aurora Saint Luke's Medical Center, Milwaukee
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565

Product Surveillance Registry

  • Madison
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Kenosha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

  • Aurora St. Luke's Medical Center, Milwaukee
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • Aurora St. Luke's Medical Center, Milwaukee
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • St Luke s Medical Center Aurora, Milwaukee
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

  • Mayo Clinic Health Systems - NW Wisconsin, Eau Claire
  • Mayo Clinic Health System SW Wisconsin, La Crosse
  • Madison VA Medical Center, Madison
  • and 4 more
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecruitingObservational study
Ages 7 and older · All sexes · Updated Aug 25, 2026 · NCT05705531

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Madison
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • University of Wisconsin, Madison
  • Advocate Aurora St. Luke's, Milwaukee
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Aurora Medical Group, Milwaukee
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • Advocate Aurora Research Institute, Milwaukee
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152

Randomized Trial of SGLT2i in Heart Transplant Recipients

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jan 22, 2026 · NCT06625073

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.